Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02661646 · ClinicalTrials.gov registry record
Quality of Life Changes on Lower Extremity Lymphedema Patients Using an Advanced Pneumatic Compression Device (PCD)
A clinical trial, sponsored by Tactile Medical.
- Terminated
- Registry status
- 249
- Enrollment target
NCT02661646: Clinical Trial study, sponsored by Tactile Medical.
NCT02661646 is a clinical trial that was terminated before completion, run by Tactile Medical. The registered enrollment target is 249 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02661646 was terminated before completion, sponsored by Tactile Medical.
- TERMINATED
- Registry status
- 249 participants
- Enrollment target
Study Summary
Assessment of quality of life and symptoms changes in primary or secondary, unilateral or bilateral lower extremity lymphedema patients using an advanced pneumatic compression system.
Primary Outcome
Questionnaires to assess quality of life changes after 12 weeks of treatment
Interventions
- DEVICE Advanced Pneumatic Compression Device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 249 participants |
| Start Date | 2015-12 |
| Est. Completion | 2023-02-01 |
Why NCT02661646 stopped before completion
NCT02661646 is an observational study that tracks outcomes without assigning an intervention. The registered 249 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Advanced Pneumatic Compression Device is the first listed.
NCT02661646 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02661646 about?
NCT02661646 is a clinical study titled "Quality of Life Changes on Lower Extremity Lymphedema Patients Using an Advanced Pneumatic Compression Device (PCD)". Assessment of quality of life and symptoms changes in primary or secondary, unilateral or bilateral lower extremity lymphedema patients using an advanced pneumatic compression system.
What is the current status of trial NCT02661646?
This trial is currently terminated. The enrollment target is 249 participants. The study started on 2015-12. Estimated completion is 2023-02-01.
What interventions are being tested in trial NCT02661646?
The interventions under investigation include: Advanced Pneumatic Compression Device (DEVICE).
Who is sponsoring clinical trial NCT02661646?
This trial is sponsored by Tactile Medical, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04628767 · 249 participants · Phase 2
Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract Cancer
- NCT05834907 · 249 participants · NA
Hands and Hearts Together
- NCT06067555 · 249 participants · Early Phase 1
Intradermal Influenza Vaccination
- NCT06588478 · 249 participants · Phase 2
A Study Evaluating the Efficacy and Safety of Pirtobrutinib in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia